Traws Pharma Inc. Insider Trading

TRAW

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jan 2022.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Jan 2022

Jan 28, 2022

Get an email when TRAW's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 16	Orbimed Capital GP Viii LLC Large holder	Bought	597,729	$1.67	998K	99%	Form 4

Apr 16
Orbimed Capital GP Viii LLC
Large holder · bought 597,729 at $1.67
998K
99% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TRAW, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with TRAW

CompareIntrinsic value

BIOEBio Essence Corp

$0.47+0.00%80

CNTBConnect Biopharma Holdings Ltd.

$0.78+0.90%10

VTGNVistaGen Therapeutics Inc.

$0.18+5.88%10

UPBUpstream Bio, Inc.

$3.70+9.14%21

PMHSPolomar Health Services Inc.

$0.19+0.00%40

KRROKorro Bio Inc.

$16.62+4.79%10

XBIOXenetic Biosciences Inc.

$2.01-3.37%40

TXMDTherapeuticsMD, Inc.

$1.82+2.25%25

Spot a number that looks wrong? Check it in TRAW's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TRAW

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.